Literature DB >> 3809719

Acute effect of cisplatin on renal hemodynamics and tubular function in dog kidneys.

G Daugaard, U Abildgaard, N H Holstein-Rathlou, P P Leyssac, O Amtorp, T G Dikhoff.   

Abstract

The present study was designed to investigate the early hemodynamic and tubular effects of cisplatin administration on dogs. To localize the nephrotoxic actions of cisplatin, we have taken advantage of the lithium clearance method. After infusion of 5 mg of cisplatin per kg, an immediate and significant increase in urinary flow rate (from 0.39 +/- 0.07 ml/min to 0.73 +/- 0.12 ml/min), sodium clearance (from 0.33 +/- 0.11 ml/min to 0.65 +/- 0.14 ml/min), potassium clearance (from 9.23 +/- 0.48 ml/min to 10.77 +/- 0.95 ml/min), lithium clearance (from 15.55 +/- 2.21 ml/min to 23.76 +/- 4.00 ml/min) and fractional lithium clearance (from 0.31 +/- 0.03 to 0.44 +/- 0.04) was seen. This occurred without measurable changes in glomerular filtration rate and renal blood flow. The calculated fractional as well as absolute rates of proximal reabsorption of sodium decreased significantly from 0.68 +/- 0.03 to 0.56 +/- 0.04 and from 4.76 +/- 0.32 mmol/min to 3.92 +/- 0.23 mmol/min, respectively. The results show that administration of cisplatin causes an acute, mainly proximal tubular impairment in dogs without alterations in renal hemodynamics.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3809719     DOI: 10.1159/000173095

Source DB:  PubMed          Journal:  Ren Physiol        ISSN: 0378-5858


  9 in total

Review 1.  Cisplatin nephrotoxicity. A review.

Authors:  G Daugaard; U Abildgaard
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

2.  Acute cisplatin nephrotoxicity in the rat. Evidence for impaired entry of sodium into proximal tubule cells.

Authors:  M J Field; T E Bostrom; F Seow; A Z Györy; D J Cockayne
Journal:  Pflugers Arch       Date:  1989-09       Impact factor: 3.657

3.  Cisplatin-induced reductions in renal functional reserve uncovered by unilateral nephrectomy: an experimental study in the pig.

Authors:  M E Robbins; D Campling; E Whitehouse; J W Hopewell; A Michalowski
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

Review 4.  Cisplatin-induced renal toxicity and toxicity-modulating strategies: a review.

Authors:  V Pinzani; F Bressolle; I J Haug; M Galtier; J P Blayac; P Balmès
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

5.  Nephrotoxicity of acyclovir and cis-diamminedichloroplatinum(II)--effect of co-administration in rats.

Authors:  J Hannemann; W Wunderle; K Baumann
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

6.  Influence of hydration on ultrafilterable platinum kinetics and kidney function in patients treated with cis-diamminedichloroplatinum(II).

Authors:  M Dumas; C de Gislain; P d'Athis; V Chadoint-Noudeau; A Escousse; J Guerrin; N Autissier
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

7.  Vitamin e is a nephroprotectant agent in male but not in female in a model of Cisplatin-induced nephrotoxicity.

Authors:  Sima Jilanchi; Mehdi Nematbakhsh; Mehrnoosh Bahadorani; Ardeshir Talebi; Fatemeh Eshraghi-Jazi; Azam Mansouri; Farzaneh Ashrafi
Journal:  ISRN Nephrol       Date:  2013-06-23

8.  Effect of Oral Magnesium Oxide Supplementation on Cisplatin-Induced Hypomagnesemia in Cancer Patients: A Randomized Controlled Trial.

Authors:  Maryam Zarif Yeganeh; Masoud Vakili; Ali Shahriari-Ahmadi; Marzieh Nojomi
Journal:  Iran J Public Health       Date:  2016-01       Impact factor: 1.429

9.  Diuretic response to cyclophosphamide in rats bearing a matrix metalloproteinase-9-producing tumour.

Authors:  Y Mizushima; K Sassa; T Hamazaki; T Fujishita; R Oosaki; M Kobayashi
Journal:  Br J Cancer       Date:  1998-10       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.